State Street’s Jaguar Health JAGX Stock Holding History

State Street’s Portfolio JAGX Stock Details JAGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-19	Closed	-$15.3K	–	4304
2024 Q4	$15.3K	Hold	19	–	–	﹤0.01%	4253
2024 Q3	$20.4K	Buy	+19	New	+$27.6K	﹤0.01%	4225
2023 Q1	–	Hold	0	–	-$12.2K	–	4802
2022 Q4	–	Hold	0	–	–	–	4787
2022 Q3	–	Hold	0	–	–	–	4817
2022 Q2	–	Hold	0	–	–	–	4757
2022 Q1	–	Hold	0	–	–	–	4660
2021 Q4	–	Hold	0	–	–	–	4493
2021 Q3	–	Hold	0	–	–	–	4200
2021 Q2	–	Hold	0	–	–	–	3780

Other funds holding JAGX

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

State Street's JAGX Position: Q1 2025 in Review

State Street sold out of Jaguar Health (JAGX) in Q1 2025, closing a stake of 19 shares — an estimated $15.3K sold.

State Street first reported a position in JAGX in Q3 2024 and held it in 2 quarters. The position peaked at $20.4K in Q3 2024. 4 funds tracked by Wall St. Rank hold JAGX as of Q1 2025.

State Street reported no remaining Jaguar Health position as of Q1 2025 after selling out during the quarter.
State Street sold 19 Jaguar Health shares in Q1 2025, an estimated $15.3K.
State Street first reported a position in Jaguar Health in Q3 2024 and held it in 2 quarters.
State Street's Jaguar Health position peaked at $20.4K in Q3 2024.
4 funds tracked by Wall St. Rank held Jaguar Health as of Q1 2025.

Based on State Street's 13F filing for Q1 2025, filed 15 May 2025.